Treatment

Resource
September 11, 2018

The International Partnership for Microbicides (IPM) 2017 annual report takes a look at promising woman-centered technologies that could expand women's prevention options and help empower them to protect their sexual and reproductive health on their own terms.

Resource
September 11, 2018

This fact sheet provides detailed information for patients about the non-nucleoside reverse transcriptase inhibitor (NNRTI) Doravirine (Pifeltro).

Resource
September 11, 2018

This fact sheet provides detailed information for patients about the combination antiretroviral drug Delstrigo.

Resource
September 11, 2018

This booklet provides information on living well with HIV as you get older.

Resource
September 4, 2018

The Accelerating Children’s HIV/AIDS Treatment (ACT) Initiative was a public-private partnership that expanded pediatric HIV services in nine sub-Saharan African countries from 2014-2016, providing treatment to more than 560,000 children living with HIV.

Opportunity
August 24, 2018

The HIV Prevention Research Advocacy Fellows Program pairs emerging leaders in advocacy and activism with existing organizations to develop and execute creative, context-specific projects focused on HIV prevention research.

News
July 27, 2018

Two large studies of community-based universal test and treat campaigns to promote HIV diagnosis, treatment and prevention, presented at the 22nd International AIDS Conference (AIDS 2018) in Amsterdam on Wednesday, show that the campaigns achieved ver

Blog
July 26, 2018
Gcobisa Madlolo, a young woman from South Africa, proud pre-exposure prophylaxis (PrEP) user, and now a global ambassador, shares her AIDS 2018 experience.
Blog
July 25, 2018
Bright and early Wednesday morning, nine speakers and more than 70 participants from international development organizations, donor agencies, and academia gathered at AIDS 2018 to discuss best practices and lessons learned from The Accelerating Children’s HIV/AIDS Treatment (ACT), reflecting how we can sustain and continue to accelerate progress in reaching children and adolescents living with HIV. Participants asked thoughtful questions and engaged in lively discussion with the panel of speakers, including reflection on challenges with case identification and the need for countries to strategically position point of care diagnostics.